Standard BioTools Inc.

Healthcare

NASDAQ:LAB · NASDAQ Global Select

Market Cap $323.89M Beta 1.38 P/E (TTM) -3.5

$0.83 +3.38%

+$0.03 today

52W Low $0.79High $1.72

Vol 3.29M · Avg 2.91M

EPS (TTM) -$0.24Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-32.54%

Period High

$1.68

Period Low

$0.80

Latest

$0.83

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Avanos Medical, Inc.

NYSE:AVNS

$1.17B

Cullinan Therapeutics, Inc.

NASDAQ:CGEM

$932.93M

CeriBell, Inc.

NASDAQ:CBLL

$671.59M

Bioventus Inc.

NASDAQ:BVS

$593.13M

Cytek Biosciences, Inc.

NASDAQ:CTKB

$509.47M

OrthoPediatrics Corp.

NASDAQ:KIDS

$471.32M

Varex Imaging Corporation

NASDAQ:VREX

$443.73M

Treace Medical Concepts, Inc.

NASDAQ:TMCI

$264.36M

So-Young International Inc.

NASDAQ:SY

$190.91M

ADC Therapeutics S.A.

NYSE:ADCT

$138.64M

What is the latest LAB filing?

The latest filing shown is SC 13D dated Jun 12, 2026.

How many recent filings does LAB have?

Intrinsic Alpha currently shows 20 recent filings for LAB.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.